ACTIVITY OF THE ALTERNATIVE PATHWAY OF COMPLEMENT IN THE NEWBORN INFANTADAMKIN D; STITZEL A; URMSON J et al.1978; J. PEDIATR.; USA; DA. 1978; VOL. 93; NO 4; PP. 604-608; BIBL. 24 REF.Article

FORMATION IN THE PRESENCE OF C3 NEPHRITIC FACTOR (C3NEF) OF AN ALTERNATIVE PATHWAY C3 CONVERTASE CONTAINING UNCLEAVED B.DAHA MR; FEARON DT; AUSTEN KF et al.1976; IMMUNOLOGY; G.B.; DA. 1976; VOL. 31; NO 5; PP. 789-795; BIBL. 1 P.Article

ISOLATION AND CHARACTERIZATION OF RAT COMPLEMENT FACTOR B AND ITS INTERACTION WITH CELL-BOUND HUMAN C3DAHA MR; VAN ES LA.1980; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1980; VOL. 41; NO 4; PP. 849-855; BIBL. 20 REF.Article

GINGIVAL FLUID ANS SERUM IN PERIODANTAL DISEASES. II. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C₃, C₃ PROACTIVATOR (FACTOR B) AND C₄ IN GINGIVAL FLUID.SCHENKEIN HA; GENCO RJ.1977; J. PERIODONTOL.; U.S.A.; DA. 1977; VOL. 48; NO 12; PP. 778-784; BIBL. 34 REF.Article

FACTEURS DU COMPLEMENT DANS LE LUPUS ERYTHEMATEUX DISSEMINE.RODRIGO J; GUARDIA J; CABRE VERDIELL J et al.1977; LYON MED.; FR.; DA. 1977; VOL. 238; NO 17; PP. 303-305; ABS. ANGL.; BIBL. 7 REF.Article

KOMPLEMENTSPIEGEL BEI KINDERN MIT IDIOPATHISCH-NEPHROTISCHEM SYNDROM. (C3, C4 UND C3-AKTIVATOR). = LE TAUX DU COMPLEMENT CHEZ LES ENFANTS PRESENTANT UN SYNDROME NEPHROTIQUE IDIOPATHIQUE (C₃, C₄ ET ACTIVATEUR C₃)POLZ E; LUBEC G.1977; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1977; VOL. 12; NO 4; PP. 360-364; ABS. ANGL.; BIBL. 12 REF.Article

CLINICAL APPLICATIONS OF IMMUNOFIXATION: DETECTION AND QUANTITATION OF COMPLEMENT ACTIVATIONWHICHER JT; HIGGINSON J; RICHES PG et al.1980; J. CLIN. PATHOL.; ISSN 0021-9746; USA; DA. 1980; VOL. 33; NO 8; PP. 781-785; BIBL. 19 REF.Article

AKTIVIERTES C3 IN DER SYNOVIAL FLUESSIGKEIT VON PATIENTEN MIT RHEUMATOIDER ARTHRITIS UND ARTHROSE (KORRELATIONEN MIT C3, C4 UND C3-PROAKTIVATOR (BEEINFLUSSUNG DURCH LAGERUNG) = C₃ ACTIVE DANS LE LIQUIDE SYNOVIAL DES MALADES AVEC POLYARTHRITE RHUMATOIDE ET ARTHROSE (CORRELATION AVEC C₃, C₄ ET C₃-PROACTIVATEUR. INFLUENCE DE LA CONSERVATION)HASLER F; STOJAN B.1981; Z. RHEUMATOL.; ISSN 0340-1855; DEU; DA. 1981; VOL. 40; NO 1; PP. 40-43; ABS. ENG; BIBL. 19 REF.Article

LES SCLEROSES EN PLAQUES AVEC HYPOCOMPLEMENTEMIE. 26 OBSERVATIONS.TROUILLAS P; MOINDROT J; AIMARD G et al.1976; LYON MED.; FR.; DA. 1976; VOL. 235; NO 10; PP. 853-859; ABS. ANGL.; BIBL. 1 P. 1/2Article

Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMAILLET, F; KAZATCHKINE, M. D; GLOTZ, D et al.Molecular immunology. 1983, Vol 20, Num 12, pp 1401-1404, issn 0161-5890Article

SYNTHESIS OF FACTORS D, B AND P OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION, AS WELL AS OF C3, BY GUINEA-PIG PERITONEAL MACROPHAGES IN VITROBENTLEY C; FRIES W; BRADE V et al.1978; IMMUNOLOGY; GBR; DA. 1978; VOL. 35; NO 6; PP. 971-980; BIBL. 24 REF.Article

REPRODUCIBLE IN VITRO PREPARATION OF INTERMEDIATE C3D COATED RED BLOOD CELLSHOFFMAN NL; MONROE MC; CHAPLIN H JR et al.1982; TRANSFUSION (PHILA.); ISSN 0041-1132; USA; DA. 1982; VOL. 22; NO 3; PP. 180-184; BIBL. 7 REF.Article

INACTIVATOR OF THE THIRD COMPONENT OF COMPLEMENT AS AN INHIBITOR IN THE PROPERDIN PATHWAYALPER CA; ROSEN FS; LACHMANN PJ et al.1972; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1972; VOL. 69; NO 10; PP. 2910-2913; BIBL. 20 REF.Serial Issue

Reduction of the β-Cys-γ-Glu thiol ester bond of human C3 with sodium borohydrideTHOMAS, M. L; DAVIDSON, F. F; TACK, B. F et al.The Journal of biological chemistry (Print). 1983, Vol 258, Num 22, pp 13580-13586, issn 0021-9258Article

POLYMORPHISM OF THE THIRD COMPONENT OF HUMAN COMPLEMENTDAVRINCHE C; RIVAT C.1982; REV. FR. TRANSFUS. IMMUNOHEMATOL.; ISSN 0338-4535; FRA; DA. 1982; VOL. 25; NO 2; PP. 199-213; ABS. FRE; BIBL. 77 REF.Article

B-CELL LYMPHOMA LACKING FC- AND C3D-RECEPTORSTHIEL E.1978; BLUT; DEU; DA. 1978; VOL. 37; NO 6; PP. 307-312; ABS. GER; BIBL. 23 REF.Article

THE INCORPORATION OF C3 NEPHRITIC FACTOR (C3NEF) INTO A STABILIZED C3 CONVERTASE, C3BBB (C3NEF), AND ITS RELEASE AFTER DECAY OF CONVERTASE FUNCTION.DAHA MR; AUSTEN KF; FEARON DT et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 812-817; BIBL. 19 REF.Article

GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article

ISOLATION AND CHARACTERIZATION OF THE C3B-BINDING ENTITY OF C3B-RECEPTOR FROM HUMAN ERYTHROCYTESMUSSEL HH; EHLEN T; SCHMITT M et al.1982; IMMUNOL. LETT.; ISSN 0165-2478; NLD; DA. 1982; VOL. 4; NO 1; PP. 1-6; BIBL. 17 REF.Article

RED BLOOD CELL-BOUND C3D IN NORMAL SUBJECTS AND IN RANDOM HOSPITAL PATIENTSFREEDMAN J; BAREFOOT C.1982; TRANSFUSION (PHILADELPHIA); ISSN 0041-1132; USA; DA. 1982; VOL. 22; NO 6; PP. 511-514; BIBL. 21 REF.Article

RED BLOOD CELL-BOUND C3D IN SELECTED HOSPITAL PATIENTSFREEDMAN J; HO M; BAREFOOT C et al.1982; TRANSFUSION (PHILADELPHIA); ISSN 0041-1132; USA; DA. 1982; VOL. 22; NO 6; PP. 515-520; BIBL. 17 REF.Article

COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASSHASLAM PL; TOWNSEND PJ; BRANTHWAITE MA et al.1980; ANAESTHESIA; GBR; DA. 1980; VOL. 35; NO 1; PP. 22-26; BIBL. 7 REF.Article

A NEW ACTIVITY OF COMPLEMENT COMPONENT C3: CELL-BOUND C3B POTENTIATES LYSIS OF ERYTHROCYTES BY C5B,6 AND TERMINAL COMPONENTS.HAMMER CH; ABRAMOWITZ AS; MAYER MM et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 3; PP. 830-834; BIBL. 16 REF.Article

THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION. THE ROLE OF C3 AND ITS INACTIVATOR (KAF)NICOL PAE; LACHMANN PJ.1973; IMMUNOLOGY; G.B.; DA. 1973; VOL. 24; NO 2; PP. 259-275; BIBL. 1 P.1/2Serial Issue

PLATELET-ASSOCIATED COMPLEMENT C₃ IN IMMUNE THROMBOCYTOPENIC PURPURAMYERS TJ; KIM BK; STEINER M et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 5; PP. 1023-1028; BIBL. 37 REF.Article